UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
2009, Etudes montaignistes, ISBN 2812400684, Volume 54., 571
Book
Inflammatory bowel diseases, ISSN 1078-0998, 09/2019, Volume 25, Issue 9, pp. E113 - E113
Journal Article
Renaissance and Reformation, ISSN 0034-429X, 12/2011, Volume 33, Issue 4, pp. 120 - 129
Journal Article
4.
Full Text
Compromised user credentials detection in a digital enterprise using behavioral analytics
Future generation computer systems, ISSN 0167-739X, 04/2019, Volume 93, pp. 407 - 417
Journal Article
Book
1971
Book
Book
01/1672
Book
9.
Full Text
Adjuvant endocrine therapy for premenopausal women: risk stratification, type and duration
Breast (Edinburgh), ISSN 0960-9776, 11/2019, Volume 48 Suppl 1, pp. S85 - S88
Drug Administration Schedule | Follow-Up Studies | Premenopause | Risk Assessment | Humans | Middle Aged | Neoplasm Recurrence, Local - therapy | Combined Modality Therapy | Neoplasm Recurrence, Local - etiology | Randomized Controlled Trials as Topic | Breast Neoplasms - therapy | Young Adult | Disease-Free Survival | Time Factors | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antineoplastic Agents, Hormonal - therapeutic use | Tamoxifen - therapeutic use | Adult | Female | Ovary - drug effects | Androstadienes - therapeutic use | Chemotherapy, Adjuvant | Aromatase Inhibitors - therapeutic use | Ovary - physiopathology | Index Medicus
Journal Article
Breast (Edinburgh), ISSN 0960-9776, 11/2019, Volume 48, p. S24
Journal Article
11.
Full Text
Strategies for the discovery and development of therapies for metastatic breast cancer
Nature reviews. Drug discovery, ISSN 1474-1776, 06/2012, Volume 11, Issue 6, pp. 479 - 497
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Biotechnology & Applied Microbiology | Science & Technology | Humans | Antineoplastic Agents - therapeutic use | Biomarkers, Tumor | Breast Neoplasms - drug therapy | Drug Discovery | Disease Progression | Drug Delivery Systems | Animals | Neoplasm Metastasis - drug therapy | Breast Neoplasms - pathology | Neoplasm Metastasis - pathology | Female | Mammary Neoplasms, Animal | Disease Models, Animal | Antimitotic agents | Breast cancer | Genetic aspects | Diagnosis | Research | Drug therapy | Antineoplastic agents | Health aspects | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 03/2013, Volume 31, Issue 7, pp. 860 - 867
Life Sciences & Biomedicine | Oncology | Science & Technology | Gynecology. Andrology. Obstetrics | Mammary gland diseases | Biological and medical sciences | Medical sciences | Tumors | Predictive Value of Tests | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Lymph Nodes - pathology | Prognosis | Breast Neoplasms - immunology | Humans | Middle Aged | Receptors, Estrogen - analysis | Breast Neoplasms - chemistry | Fluorouracil - administration & dosage | Lymphocytes, Tumor-Infiltrating | Adult | Female | Chemotherapy, Adjuvant | Doxorubicin - administration & dosage | Biomarkers, Tumor - analysis | Kaplan-Meier Estimate | Treatment Outcome | Lymphatic Metastasis | Breast Neoplasms - drug therapy | Antibiotics, Antineoplastic - administration & dosage | Disease-Free Survival | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Methotrexate - administration & dosage | Aged | Receptor, ErbB-2 - analysis | Index Medicus
Journal Article
Breast (Edinburgh), ISSN 0960-9776, 11/2017, Volume 36, pp. S23 - S24
Journal Article
Breast (Edinburgh), ISSN 0960-9776, 08/2017, Volume 34, pp. S108 - S111
Receptors, Estrogen - metabolism | Drug Administration Schedule | Premenopause | Antineoplastic Agents, Hormonal - administration & dosage | Humans | Receptor, ErbB-2 - metabolism | Tamoxifen - administration & dosage | Breast Neoplasms - metabolism | Breast Neoplasms - therapy | Disease-Free Survival | Androstadienes - administration & dosage | Time Factors | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antineoplastic Agents, Hormonal - therapeutic use | Tamoxifen - therapeutic use | Female | Chemotherapy, Adjuvant | Chemotherapy | Care and treatment | Analysis | Menopause | Oncology, Experimental | Mortality | Estrogen | Research | Tamoxifen | Cancer | Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 2015, Volume 16, Issue 7, pp. 848 - 858
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Follow-Up Studies | Humans | Middle Aged | Dose-Response Relationship, Drug | Antineoplastic Agents, Hormonal - adverse effects | Neoplasm Invasiveness - pathology | Antineoplastic Agents, Hormonal - therapeutic use | Adult | Female | Ovary - drug effects | Chemotherapy, Adjuvant | Drug Administration Schedule | Risk Assessment | Administration, Oral | Early Detection of Cancer | Self Report | Treatment Outcome | Breast Neoplasms - drug therapy | Disease-Free Survival | Breast Neoplasms - pathology | Tamoxifen - therapeutic use | Premenopause - physiology | Survival Analysis | Quality of Life | Breast Neoplasms - mortality | Tamoxifen - adverse effects | Neoplasm Staging | Index Medicus
Journal Article
Breast (Edinburgh), ISSN 0960-9776, 2013, Volume 22, pp. S23 - S23
Journal Article
The New England journal of medicine, ISSN 0028-4793, 07/2018, Volume 379, Issue 2, pp. 122 - 137
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Breast Neoplasms - surgery | Follow-Up Studies | Neoplasm Recurrence, Local - prevention & control | Premenopause | Humans | Middle Aged | Kaplan-Meier Estimate | Breast Neoplasms - drug therapy | Young Adult | Antineoplastic Agents, Hormonal - adverse effects | Disease-Free Survival | Aromatase Inhibitors - adverse effects | Antineoplastic Agents, Hormonal - therapeutic use | Tamoxifen - therapeutic use | Adult | Female | Androstadienes - therapeutic use | Receptor, ErbB-2 | Chemotherapy, Adjuvant | Tamoxifen - adverse effects | Androstadienes - adverse effects | Aromatase Inhibitors - therapeutic use | Women | Care and treatment | Usage | Hormone therapy | Analysis | Breast cancer | Health aspects | Medical research | Oncology | Tamoxifen | Cancer therapies | Survival | ErbB-2 protein | Studies | Design | Chemotherapy | Hospitals | Womens health | Aromatase | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article